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Summary
Background Improved understanding of pathogens that cause sepsis would aid management and antimicrobial 
selection. In this study, we aimed to identify the causative pathogens of sepsis in southeast Asia.
Methods In this multinational multicentre cross-sectional study of community-acquired sepsis and severe sepsis, we 
prospectively recruited children (age ≥30 days and <18 years) and adults (age ≥18 years) at 13 public hospitals in 
Indonesia (n=3), Thailand (n=4), and Vietnam (n=6). Hospitalised patients with suspected or documented community-
acquired infection, with at least three diagnostic criteria for sepsis according to the Surviving Sepsis Campaign 2012, 
and within 24 h of admission were enrolled. Blood from every patient, and nasopharyngeal swab, urine, stool, and 
cerebrospinal ﬂ uid, if indicated, were collected for reference diagnostic tests to identify causative pathogens. We 
report causative pathogens of sepsis and 28-day mortality. We also estimate mortality associated with enrolment with 
severe sepsis. This study was registered with ClinicalTrials.gov, number NCT02157259.
Findings From Dec 16, 2013, to Dec 14, 2015, 4736 patients were screened and 1578 patients (763 children and 
815 adults) were enrolled. Dengue viruses (n=122 [8%]), Leptospira spp (n=95 [6%]), rickettsial pathogens (n=96 [6%]), 
Escherichia coli (n=76 [5%]), and inﬂ uenza viruses (n=65 [4%]) were commonly identiﬁ ed in both age groups; whereas 
Plasmodium spp (n=12 [1%]) and Salmonella enterica serovar Typhi (n=3 [0·2%]) were rarely observed. Emerging 
pathogens identiﬁ ed included hantaviruses (n=28 [2%]), non-typhoidal Salmonella spp (n=21 [1%]), Streptococcus suis 
(n=18 [1%]), Acinetobacter spp (n=12 [1%]), and Burkholderia pseudomallei (n=5 [<1%]). 28-day mortality occurred in 
14 (2%) of 731 children with known statuses and 108 (13%) of 804 adults. Severe sepsis was identiﬁ ed on enrolment 
in 194 (28%) of 731 children and 546 (68%) of 804 adults, and was associated with increased mortality (adjusted odds 
ratio 5·3, 95% CI 2·7–10·4; p<0·001).
Interpretation Sepsis in southeast Asia is caused by a wide range of known and emerging pathogens, and is associated 
with substantial mortality.
Funding National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 
USA, and Wellcome Trust, UK. 
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. 
Introduction
Sepsis is the presence of systemic host responses to 
infection. Severe sepsis and septic shock are major 
health-care problems and kill millions of people annually 
worldwide.1–3 To reduce mortality, understanding of the 
causes of sepsis needs to be improved; however, this 
information is rarely available in tropical countries.4 In 
southeast Asia, a wide range of known and emerging 
pathogens could cause infections leading to sepsis 
and severe sepsis.5 Several studies have examined causes 
of fever6–10 and bacteraemia11 in the region. However, 
none applied a predeﬁ ned wide array of diagnostic tests 
and assessed the relative distribution of pathogenic 
bacterial, parasitic, and viral agents identiﬁ ed in patients 
admitted with community-acquired sepsis. Also, no 
single study has been conducted in multiple study sites 
in multiple countries.
The diagnostic criteria for sepsis and severe sepsis have 
been modiﬁ ed over time. The initial deﬁ nition of sepsis 
was developed in 1991 through the concept of the Systemic 
Inﬂ ammatory Response Syndrome (SIRS), which was 
characterised by two or more of: body temperature greater 
than 38°C or less than 36°C; heart rate more than 90 beats 
per min; respiratory rate of more than 20 breaths per min 
or a PaCO2 of less than 32 mm Hg; and a white blood cell 
count of more than 12 000 cells per μL or less than 
4000 cells per μL.12 Recognising limitations of the initial 
deﬁ nitions, a 2001 task force expanded the list of criteria to 
diagnose sepsis to incorporate general, inﬂ ammatory, 
haemodynamic, organ dysfunction, and tissue perfusion 
variables in addition to suspected or documented 
infection.13 The expanded diagnostic criteria for sepsis 
have been adopted and recommended by the surviving 
sepsis campaign (SSC) in 2004,1 2008,2 and 2012.3 A 2014 
task force14 concluded that the term severe sepsis was 
redundant and recommended that the new updated 
deﬁ nitions and clinical criteria for sepsis should replace 
previous deﬁ nitions so that the reported incidence and 
observed mortality are comparable worldwide, and early 
recognition and timely management can be provided for 
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patients who are likely to have poor outcomes. In this 
study, we aimed to evaluate causes and mortality outcome 
of sepsis and severe sepsis based on the SSC 
2012 deﬁ nitions, and did an additional analysis using the 
deﬁ nition of the 2014 task force.
Methods
Study design
We conducted a prospective observational study of 
community-acquired sepsis and severe sepsis in 13 public 
hospitals in Indonesia (Dr Cipto Mangunkusumo Hospital, 
Jakarta; Dr. Sardjito Hospital, Yogyakarta; and Dr Wahidin 
Soedirohusodo Hospital, Makassar), Thailand (Queen 
Sirikit National Institute of Child Health and Siriraj 
Hospital, Bangkok; Chiang Rai Prachanukroh Hospital, 
Chiang Rai; and Sappasithiprasong Hospital, Ubon 
Ratchathani), and Vietnam (National Hospital of Paediatrics 
and National Hospital of Tropical Diseases, Hanoi; Hue 
Central Hospital, Hue; Children’s Hospital 1, Children’s 
Hospital 2, and Hospital for Tropical Diseases, Ho Chi Minh 
City; appendix). All are tertiary public hospitals equipped 
with microbiology facilities and intensive care units, with a 
median bed number of 1200 (range 350–2200). The study 
protocol and related documents were approved by regional 
and national Ethics Committees.
Participants
We prospectively enrolled paediatric (≥30 days and 
<18 years) and adult patients (≥18 years) who were admitted 
with a primary diagnosis of suspected or documented 
infection (made by the attending physician), were within 
24 h of hospital admission, and had at least three sepsis 
diagnostic criteria documented in the medical record. For 
adult patients, we used 19 variables that were consolidated 
from the 22 variables proposed as diagnostic criteria for 
sepsis by the SSC 2012,3 and included low oxygen 
saturation (SpO2<95%; panel 1). This variable was added 
because oxygen saturation determined by pulse oximeter 
is recommended by WHO guidelines for limited-resource 
settings.15 Altered mental status was deﬁ ned as a Glasgow 
Coma Scale (GCS) score of less than 15, or less than 10 if 
intubated. For paediatric patients, in addition to three 
diagnostic criteria of fever or hypothermia, tachycardia, 
and tachypnoea, patients had to have at least one of the 
following symptoms: altered mental status, hypotension, 
hypoxaemia, and leukocytosis (panel 2). We excluded 
patients who were suspected of having hospital-acquired 
infections determined by the attending physician, had a 
hospital stay within 30 days before this admission, or were 
transferred from other hospitals with a total duration of 
hospitalisation of more than 72 h. Owing to concerns 
about the volume of blood drawn from each patient, we 
also excluded patients who had been enrolled into other 
clinical studies.
Procedures
The study was initiated on Dec 16, 2013, in Thailand, 
March 24, 2014, in Vietnam, and March 9, 2015, in 
Research in context
Evidence before this study
We searched PubMed for prospective studies that evaluated 
causes of fever, sepsis, and severe sepsis in southeast Asia, and 
were published in English between Jan 1, 1984, and 
Dec 31, 2014, using the following terms “sepsis” [MeSH term] 
AND (“Asia, Southeastern” [MeSH term]). We identiﬁ ed 
34 studies. None of the studies applied inclusion criteria of the 
surviving sepsis campaign (SSC) to patients presenting with 
sepsis in southeast Asia. Several studies have examined causes 
of fever and bacteraemia in southeast Asia. However, none 
applied a predeﬁ ned wide array of diagnostic tests and assessed 
the relative distribution of pathogenic bacterial, parasitic, and 
viral agents identiﬁ ed in patients admitted with 
community-acquired sepsis in southeast Asia.
Added value of this study
To our knowledge, this study is the ﬁ rst that aimed to identify 
potential causes of sepsis using a predeﬁ ned set of diagnostic 
tests covering a wide range of viruses, bacteria, and parasites in 
southeast Asia. Typhoid fever and malaria were rarely identiﬁ ed 
in our study hospitals, which are situated in big cities in 
Indonesia, Thailand, and Vietnam. We observed a number of 
emerging pathogens including hantavirus, non-typhi 
Salmonella spp, Streptococcus suis, Acinetobacter spp, and 
Burkholderia pseudomallei. We observed that clinical 
presentations of many tropical infectious diseases, including 
dengue infection, leptospirosis, and rickettsioses were not 
speciﬁ c. We show that mortality of sepsis in developing 
countries in southeast Asia is substantial, and severe sepsis 
deﬁ ned by SSC 2012 is associated with mortality. We also 
showed that sepsis deﬁ ned by the 2014 task force (total 
sequential organ failure assessment score ≥2) was associated 
with mortality in adult patients. One of the strengths of our 
study is that the mortality for sepsis observed is robust because 
we contacted participants to ascertain 28-day mortality 
outcomes—many people in developing countries prefer to die 
at home, and in-hospital mortality alone could underestimate 
the mortality of sepsis in developing countries.
Interpretations of all the available evidence
To reduce mortality of sepsis in this region, rapid, inexpensive, 
and accurate multidisease diagnostic tests for tropical 
developing countries is urgently needed. The diagnostic 
criteria for sepsis and severe sepsis recommended by SSC are 
applicable to tropical developing countries, and could be used 
to determine patients who are at high risk of death from 
infectious diseases. 
See Online for appendix
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Indonesia. The study enrolment was closed on 
Dec 14, 2015, in all three countries. The study team used a 
standardised case-report form to record the clinical 
symptoms and their respective durations, known chronic 
conditions, laboratory tests performed by the study 
hospital laboratories, and primary and ﬁ nal diagnoses 
made by attending clinicians. As per protocol, every 
patient was evaluated by the study team, and the following 
rapid tests were performed immediately after enrolment: 
a whole blood lactate rapid diagnostic test (RDT; Lactate 
Pro 2, Arkray Global Business, Kyoto, Japan), a whole 
blood glucose RDT (ACCU-CHECK Performa, Roche 
Diagnostics, Mannheim, Germany), pulse oximeter 
(Nellcor N-65, Covidien, Dublin, Ireland), and dengue 
RDTs (NS1 and IgM, Standard Diagnostics, Gyeonggi-do, 
South Korea). All children younger than 7 years old were 
evaluated using an inﬂ uenza RDT (QuickVue, Quidel 
Corporation, San Diego, CA, USA), and all patients aged 
7 years or older were evaluated using a leptospirosis RDT 
(Leptospira IgM/IgG, Standard Diagnostics). The results 
of all rapid tests were reported to the attending physicians. 
In all cases, blood samples (4–10 mL) were collected for 
culture on site and for serological tests and molecular 
tests at reference laboratory centres of each country. 
Pooled nasal and throat swabs were collected for 
respiratory viruses if patients had respiratory symptoms. 
Stool samples were collected if patients had diarrhoeal 
symptoms. Residual cerebrospinal ﬂ uid (CSF) was 
collected if available. A set of reference diagnostic tests 
was performed for each patient according to clinical 
presentation (appendix). These tests included complete 
blood count, blood culture, and urinary analysis and urine 
culture in every study patient, sputum Gram smears and 
sputum culture if patients had respiratory symptoms, 
stool examination and stool culture if patients had 
diarrhoeal symptoms, and CSF examination and CSF 
culture if patients had neurological symptoms and CNS 
infection was suspected (appendix).
The study did not involve any clinical interventions. All 
treatments were provided by attending physicians and 
their medical teams. The rainy season was from 
November to March in Indonesia, July to October in 
Thailand, April to October in northern Vietnam, 
September to January in central Vietnam, and May to 
November in southern Vietnam. The 28-day mortality 
was evaluated via telephone contact if participants were 
no longer hospitalised and had been discharged alive.
Deﬁ nitions
For each patient, the clinical presentations (in some 
cases, more than one) were deﬁ ned based on the major 
presenting clinical symptoms. Acute respiratory infection 
was deﬁ ned as manifestation of at least one respiratory 
symptom for no longer than 14 days. Acute diarrhoea was 
deﬁ ned as diarrhoea for no longer than 14 days. Acute 
CNS infection was deﬁ ned as manifestation of CNS 
symptoms for no longer than 14 days or presence of signs 
of CNS infection on admission. Systemic infection was 
deﬁ ned as absence of acute respiratory infection, acute 
diarrhoea and acute CNS infection.
To maximise consistency and minimise subjectivity, 
identiﬁ cation of the pathogens was done using a 
computer-based algorithm (appendix) and conﬁ rmed by 
Panel 1: Diagnostic criteria for sepsis in adult patients
Infection, documented or suspected, and some of the 
following:
General variables
• Fever or hypothermia (body temperature >38·3oC or 
<36oC)*
• Heart rate >90 beats per min
• Tachypnoea (respiratory rate >20 breaths per min)
• Altered mental status (Glasgow Coma Scale <15 or <10 if 
intubated)†
• Signiﬁ cant oedema or positive ﬂ uid balance (>20 mL/kg 
over 24 h)
• Hyperglycaemia (plasma glucose >140 mg/dL) in the 
absence of diabetes
Inﬂ ammatory variables
• Leukocytosis (white blood cell count >12 000 cells per μL), 
leucopenia (white blood cell count <4000 cells per μL), or 
immature forms >10%‡
• Plasma C-reactive protein more than 2 SD above the 
normal value
• Plasma procalcitonin more than 2 SD above the normal 
value
Haemodynamic variables
• Arterial hypotension (systolic blood pressure <90 mm Hg, 
mean arterial pressure <70 mm Hg, or a systolic blood 
pressure decrease >40 mm Hg)
Organ dysfunction variables
• Low oxygen saturation determined by pulse oximetry 
(SpO2 <95%)§
• Arterial hypoxaemia (PaO2/FiO2 <300)
• Acute oliguria (urine output <0·5 mL/kg per h for at 
least 2 h)¶
• Creatinine increase >0·5 mg/dL
• Coagulation abnormalities (international normalised 
ratio >1·5 or activated partial thromplastin time >60 s)
• Ileus (absent bowel sounds)
• Thrombocytopenia (platelet count <100 000 cells per μL)
• Hyperbilirubinaemia (plasma total bilirubin >4 mg/dL)
Tissue perfusion variables
• Hyperlactataemia (>1 mmol/L)
• Decreased capillary reﬁ ll or mottling
*Variables fever and hypothermia were consolidated into a single variable. †Glasgow 
Coma Scale <15 or <10 if intubated were deﬁ ned for the altered mental status variable. 
‡Variables leukocytosis, leukopenia, and immature forms >10% were consolidated into 
a single variable. §Variable low oxygen saturation determined by pulse oximetry (SpO2 
<95%) was added. ¶A condition of “despite adequate ﬂ uid resuscitation” is included 
for this criterion in the SSC 2012 diagnostic criteria for severe sepsis. Adapted from 
Dellinger and colleagues.3 
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an adjudication committee. The blood culture result was 
considered contaminated if growth of coagulase-negative 
staphylococci, alpha-haemolytic streptococci, Micro coccus 
spp, Propionibacterium spp, Corynebac terium spp, Burk-
holderia cepacia, or Bacillus spp was detected without 
additional evidence of clinical diagnoses suggesting true 
infection (eg, endocarditis, artiﬁ cial material in situ). 
Rickettsial pathogens evaluated were Orientia tsutsu-
gamushi, Rickettsia typhi, and spotted fever group 
rickettsia (appendix).
Statistical analysis
The primary objective of this study was to determine 
the causes of community-acquired sepsis and severe 
sepsis in adult and paediatric patients. We also assessed 
28-day mortality and other secondary outcomes, which 
will be reported elsewhere. We entered data into 
OpenClinica, Enterprise Edition (Waltham, MA, USA), 
and used STATA version 14.0 for all analyses. We 
calculated that 125 participants per age group per study 
area (three study areas per country [appendix] and a 
total of 750 participants per country) would provide 
adequate power (>90%) to observe a cause of sepsis, 
which had a true prevalence of 2% or greater in each 
study age group in each study area. We assessed 
diﬀ erences in proportions among groups using Fisher’s 
exact test, and diﬀ erences in medians with the Mann-
Whitney test. We used logistic regression models 
stratiﬁ ed by study sites and age group to evaluate the 
factors associated with mortality. 28-day mortality was 
deﬁ ned as the proportion of patients who died within 
28 days of hospital admission. We deﬁ ned severe sepsis 
in adult patients as described in Surviving Sepsis 
Campaign 2012,3 and in paediatric patients as previously 
described.16 We also evaluated the association between 
sepsis deﬁ ned by the 2014 task force (total sequential 
organ failure assessment [SOFA] score ≥2) and 
mortality in adult patients.14 The additional analysis was 
restricted to only adult patients because the new sepsis 
deﬁ nition is available only for this group.14 A sensitivity 
analysis was done by only including patients with a 
pathogen detected in the model. The study was 
registered with ClinicalTrials.gov, number 
NCT02157259. The ﬁ nal database and the data 
dictionary are publicly available online.
Role of the funding source
All study procedures, data collection, data analyses, data 
interpretation, and writing of the report were performed 
without the sponsors’ involvement. Full access to data 
was granted to the corresponding author. All authors 
participated in the study design or analysis, and approved 
the submission of the manuscript. The SEAICRN 
executive committee had ﬁ nal responsibility for the 
decision to submit for publication.
Results
4736 patients (2093 children and 2643 adults) presenting 
at study hospitals were screened by the study team 
during the study period (ﬁ gure 1). Common exclusion 
criteria were hospitalisation in the past 30 days (719 [15%] 
patients) and less than three sepsis diagnostic criteria 
Panel 2: Diagnostic criteria for sepsis in paediatric patients
Infection, documented or suspected, with all three of the 
following:
• Fever or hypothermia (rectal temperature >38·5oC or 
<35·0oC [or equivalent])
• Tachycardia (heart rate >2 SD above the normal value for 
age), which could be absent in hypothermic patients
• Tachypnoea (respiratory rate >2 SD above the normal 
value of age)
AND at least one of the following indices
• Altered mental status (eg, drowsiness, poor quality of cry, 
poor reaction to parent stimuli, and poor response to 
social overtures)
• Systolic blood pressure <2 SD below the normal value for 
age, narrow pulse pressure (<20 mm Hg), or poor perfusion 
(capillary reﬁ ll >2 s)
• Low oxygen saturation determined by pulse oximetry 
(SpO2 <95%)
• Leukocytosis (white blood cell count >12 000 cells per μL), 
leukopenia (white blood cell count <5000 cells per μL), 
or immature forms >10%
Adapted from Goldstein and colleagues.16 
For the final database and the 
data dictionary see https://dx.
doi.org/10.6084/m9.
figshare.3486866.v1
Figure 1: Study proﬁ le
4736 patients screened 
 2093 children 
 2643 adults
1582 patients enrolled
 766 children 
 816 adults
1578 patients analysed 
 763 children 
 815 adults
3154 patients excluded
 24 aged <30 days old or had bodyweight <3 kg
 430 suspected or diagnosed with non-infectious conditions
 24 did not require hospital admission
 277 were admitted for longer than 24 h at the study hospital  
 423 were transferred from other hospitals with a total duration of hospitalisation 
  >72 h
 719 had a hospital stay within 30 days prior to this admission
 269 had been enrolled in other clinical studies 
 667 had <3 sepsis diagnostic criteria documented in the medical record
 474 did not obtain consent  
3 pediatric and 1 adult patients excluded because incomplete enrolment criteria were found
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documented in the medical record (667 [14%] patients). 
After giving informed consent, 1582 community-
acquired sepsis patients were enrolled. The enrolment 
target was reached for Thailand and Vietnam 
(750 patients [375 children and 375 adults] per country). 
82 patients (16 children and 66 adults) were enrolled in 
Indonesia. Enrolment in Indonesia did not reach the 
target sample size because of competitive enrolment 
with other studies during the study period. Three 
enrolled children and one adult were retrospectively 
found not to fulﬁ ll the inclusion criteria and were 
excluded from the analysis.
763 children (table 1) and 815 adults (table 2) were 
included in the analysis. Characteristics of patients by 
country are shown in the appendix. Convalescent blood 
samples were obtained from 925 patients (415 children 
and 510 adults), and 36 853 diagnostic tests were done 
per protocol.
Per study protocol, 937 distinct clinical presentations 
were seen in 763 children (ﬁ gure 2) and 927 were seen in 
815 adults (ﬁ gure 3). Acute respiratory infection was the 
most frequent clinical presentation, found in 481 (63%) 
children and 436 (53%) adults, followed by acute 
diarrhoea, acute systemic infection, and acute CNS 
infection in children (ﬁ gure 2) and acute systemic 
infection, acute diarrhoea, and acute CNS infection in 
adults. Among those with acute respiratory infection, 
pneumonia was diagnosed by attending physicians in 
280 (37%) of 763 children and 222 (27%) of 815 adults. 
Other clinical presentations were distributed as follows: 
183 (24%) children and 168 (21%) adults had acute 
diarrhoea, 119 (16%) children and 80 (10%) adults had 
acute CNS infection, and 154 (20%) children and 
243 (30%) adults had systemic infection. 156 (20%) 
children and 105 (13%) adults had multiple clinical 
presentations. At least one pathogen was identiﬁ ed in 
425 (56%) children and 388 (48%) adults (ﬁ gure 4), and 
one child (<1%) and 17 (2%) adults had a ﬁ nal diagnosis 
of non-infectious causes (appendix).
Overall, dengue virus was identiﬁ ed in 55 (7%) children 
and 67 (8%) adults (appendix). Among individuals with 
acute respiratory infection, diagnostic tests were positive 
for at least one virus in 282 (59%) of 481 children and 
74 (17%) of 436 adults, including inﬂ uenza viruses 
(44 children and 20 adults), rhinovirus (92 children and 
12 adults), and respiratory syncytial virus (52 children and 
two adults; ﬁ gures 2, 3). A virus was identiﬁ ed in 76 (42%) 
of 183 children and 20 (12%) of 168 adults with acute 
diarrhoea, including rotavirus (12 children and 
two adults), adenovirus (eight children and no adults), 
and norovirus (three children and one adult). Of those 
individuals who had clinical presentation of both acute 
respiratory infection and acute diarrhoea, 57 (57%) of 
100 children and 12 (17%) of 70 adults had diagnostic tests 
Paediatric patients (n=763)
Sex
Male 433 (57%)
Female 330 (43%)
Age
≥30 days to <1 year 171 (22%)
≥1 year to <5 years 385 (50%)
≥5 years to <18 years 207 (27%)
Country
Indonesia 14 (2%)
Thailand 375 (49%)
Vietnam 374 (49%)
Pre-existing conditions
Diabetes 1 (<1%)
Hypertension 0
Chronic kidney disease 0
Chronic lung disease 1 (<1%)
HIV/AIDS 2 (<1%)
28-day mortality
Survived 717 (94%)
Died 14 (2%)
Unknown* 32 (4%)
Data are n (%). *Mortality outcome was not available in 19 children who 
withdrew from the study before 28 days of follow-up, and in another 13 children 
who could not be contacted for 28-day outcome. 
Table 1: Baseline characteristics of paediatric patients with sepsis
Adult patients (n=815)
Sex 
Male 462 (57%)
Female 353 (43%)
Age
≥18 years to <40 years   261 (32%)
≥40 years to <60 years  270 (33%)
≥60 years 284 (35%)
Country 
Indonesia 65 (8%)
Thailand 375 (46%)
VietNam 375 (46%)
Pre-existing conditions 
Diabetes 124 (15%)
Hypertension 217 (27%)
Chronic kidney disease 50 (6%)
Chronic lung disease 36 (4%)
HIV/AIDS 2 (<1%)
28-day mortality 
Survived 696 (85%)
Died 108 (13%)
Unknown* 11 (1%)
Data are n (%). *Mortality outcome was not available in ﬁ ve adults who withdrew 
from the study before 28 days of follow-up, and in another six adults who could 
not be contacted for 28-day outcome.
Table 2: Baseline characteristics of adult patients with sepsis  
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positive for at least one virus; including 20 children and 
one adult with rhinovirus (ﬁ gure 2). Viruses were 
identiﬁ ed in 40 (34%) of 119 children and ten (13%) of 
80 adults who had clinical presentation of acute CNS 
infection, including dengue virus (ten children and 
eight adults), inﬂ uenza virus (seven children and 
one adult), enterovirus (six children and no adults), and 
adenovirus (three children and no adults); hantavirus was 
identiﬁ ed in about 2% of children and adults (ﬁ gures 2, 3).
15 (2%) of 742 children and 37 (5%) of 789 adults for 
whom blood culture was done, were positive for 
contaminant bacteria; 35 (5%) children and 96 (12%) 
adults were positive for pathogenic bacteria. The most 
frequent contaminants were coagulase-negative 
Staphylococcus. Overall, 12 children and 68 adults were 
blood culture positive for Gram-negative bacteria, 
including Escherichia coli (n=40), Klebsiella 
pneumoniae (n=9), Acinetobacter spp (n=9), Enterobacter 
spp (n=6), and Burkholderia pseudomallei (n=3). 
22 children and 24 adults were blood culture positive for 
Gram-positive bacteria, including Staphylococcus aureus, 
Streptococcus pneumoniae, Streptococcus suis, and beta-
haemolytic Streptococcus spp (appendix). Among 
1444 patients with negative blood cultures, blood 16S PCR 
was positive in 44 (3%) patients. Products of 16S PCR 
could be identiﬁ ed in 14 cases; including 
S suis (n=4), Orientia tsutsugamushi (n=4), 
Pseudomonas spp (n=2), Achromobacter spp (n=1), 
S pneumoniae (n=1), K pneumoniae (n=1), and 
Enterobacteriaceae (n=1).
Figure 2: Distribution of clinical presentations and pathogens identiﬁ ed in 763 paediatric patients
Numbers in parentheses are number of clinical presentations of each pathogen identiﬁ ed. In some patients, more than one clinical presentation or more than one 
pathogen was identiﬁ ed. SFG=spotted fever group. RSV=respiratory syncytial virus. E Coli=Escherichia coli. S Aureus=Staphylococcus aureus. O tsutsugamushi=Orienta 
tsutsugamushi. S pneumoniae=Streptococcus pneumoniae. S Suis=Streptococcus suis.
Acute diarrhoeaAcute CNS infection
Acute respiratory infection
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937 clinical presentations among 763 paediatric patients
Acute respiratory
infection (n=481)
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Acute systemic
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Among patients with acute respiratory infection, 
diagnostic tests were positive for at least one bacterium 
in 93 (19%) of 491 children and 147 (34%) of 436 adults. 
These bacteria included S aureus (ten children and 
six adults), Mycoplasma spp (14 children and six adults), 
K pneumoniae (no children and nine adults), S pneumoniae 
(two children and four adults), Leptospira spp (11 children 
and 44 adults), O tsutsugamushi (11 children and 14 adults) 
and Mycobacterium tuberculosis (two children and 
four adults). A bacterium was documented in 40 (22%) of 
183 children and 60 (36%) of 168 adults with acute 
diarrhoea. These bacteria included Salmonella enterica 
serovar Typhi (no children and one adult), non-typhi 
Salmonella spp (11 children and seven adults), E coli 
(seven children and 12 adults), and Campylobacter spp 
(two children and no adults). Bacteria were identiﬁ ed in 
17 (14%) of 119 children and 42 (53%) of 80 adults with 
acute CNS infection. Those included Leptospira spp 
(two children and nine adults), E coli (three children and 
seven adults), S suis (no children and ten adults), 
S pneumoniae (four children and one adult), spotted fever 
group rickettsia (two children and two adults), and 
O tsutsugamushi (no children and three adults). Overall, 
tropical bacterial infectious diseases were common, 
including leptospirosis and rickettsioses, in both children 
and adults.
Four children and eight adults had malaria, one child 
and one adult had Entamoeba histolytica, two adults had 
strongyloidiasis, and one child had cryptosporidiosis.
Pathogens identiﬁ ed in Indonesia, Thailand, and 
Vietnam were largely comparable, except non-typhi 
Salmonella, Enterobacter spp, Acinetobacter spp, 
Figure 3: Distribution of clinical presentations and pathogens identiﬁ ed in 815 adult patients
Numbers in parentheses are number of clinical presentations of each pathogen identiﬁ ed. In some patients, more than one clinical presentation or more than one 
pathogen was identiﬁ ed. SFG=spotted fever group. RSV=respiratory syncytial virus. E Coli=Escherichia coli. S aureus=Staphylococcus aureus. O tsutsugamushi=Orienta 
tsutsugamushi. S pneumoniae=Streptococcus pneumoniae. S Suis=Streptococcus suis.
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beta-haemolytic Streptococcus spp, rickettsial pathogens, 
dengue viruses, inﬂ uenza viruses, hantaviruses, 
rotavirus, cytomegalovirus, and bocavirus (appendix). 
We found that S suis and respiratory syncytial virus 
were more commonly identiﬁ ed during rainy season, 
while inﬂ uenza viruses and rotavirus more commonly 
identiﬁ ed during dry season (appendix). Emerging 
pathogens identiﬁ ed included hantaviruses (n=28 
[2%]), non-typhoidal Salmonella spp (n=21 [1%]), 
S suis (n=18 [1%]), Acinetobacter spp (n=12 [1%]), and 
Burkholderia pseudomallei (n=5 [<1%]; appendix). 
The 28-day mortality was 14 (2%) in 731 children with 
known statuses (table 1) and 108 (13%) in 804 adults 
(table 2). Mortality outcome was not available in 
19 children and ﬁ ve adults who withdrew from the 
study before 28 days of follow-up, and in another 
13 children and six adults who could not be contacted 
for 28-day outcome. The failure to obtain 28-day 
mortality data was higher in Thailand (4%; 29 of 750) 
than in Vietnam (2%; 13 of 749) and Indonesia (1%; 
one of 79; appendix, p=0·03). Of 122 patients who died, 
32 died within 2 days (26%) and 49 between day 3 and 
7 (40%) of hospitalisation. In the multivariable logistic 
regression model, severe sepsis on admission was 
strongly associated with mortality (adjusted odds ratio 
5·3, 95% CI 2·7–10·4; p<0·001; table 3). This 
observation was in both pediatric patients (adjusted 
odds ratio [OR] 8·2, 95% CI 1·9–35·5; p=0·005) and 
adult patients (adjusted OR 4·3, 95% CI 2·0–8·9; 
p<0·001). Patients with viruses identiﬁ ed had a lower 
risk of death, which was also observed when only 
patients with pathogens identiﬁ ed were included in the 
model (appendix). In the additional analysis, adult 
patients with SOFA scores ≥2 on admission were 
associated with higher 28-day mortality than adult 
patients with SOFA scores <2 on admission adults 
(99 [22%] of 454 vs 9 [3%] of 350; adjusted OR 4·1, 
95% CI 1·6–10·3; p=0.003; appendix).
Discussion
Using a predeﬁ ned set of diagnostic tests, we were able 
to identify the possible causative organisms of sepsis 
and severe sepsis in 56% of children and 48% of adults 
enrolled in our study. Viruses were identiﬁ ed in 29% of 
patients, bacteria in 27%, and parasites in 1%. Tropical 
infectious diseases were common causes of sepsis and 
severe sepsis in our setting. These include dengue virus, 
leptospirosis, and rickettsioses. Typhoid fever was rarely 
identiﬁ ed. We also observed a number of emerging 
pathogens including hantavirus, non-typhoidal 
Salmonella spp, S suis, Acinetobacter spp, and 
B pseudomallei. Non-typhoidal Salmonella infection is 
increasingly recognised as an important cause of sepsis 
and diarrhoeal illnesses in the region.17,18 Community-
acquired Acinetobacter bacter aemia and pneumonia is 
also increasingly reported.19,20 B pseudomallei is known to 
be endemic but is generally underdiagnosed in the 
region,21 and little is known about hantavirus22,23 and 
S suis.24,25
Our study emphasises the need for rapid, inexpensive, 
and accurate multidisease diagnostic tests for tropical 
developing countries. For example, a number of both 
paediatric and adult patients with dengue in our study 
might have not been diagnosed if RDTs for dengue 
were not used in every participating patient. This 
shortcoming is because diagnostic tests are usually 
Figure 4: Overlap between pathogens identiﬁ ed in (A) 763 paediatric 
patients and (B) 815 adult patients
Numbers show number of patients not presentations. 
A
Other pathogens
and viruses identified
2 (<1%)
Other pathogens
identified alone
4 (<1%)
Bacteria
identified
alone
90 (12%)
Bacteria identified alone
251 (31%)
Other pathogens and viruses identified
1 (<1%)Other pathogens
identified alone
11 (1%)
Viruses
identified
alone
96 (12%)
Bacteria and
viruses
identified
29 (4%)
Bacteria
and viruses
identified
54 (7%)
Viruses identified alone
275 (36%)
No pathogens identified
338 (44%)
No pathogens identified
427 (52%)
B
Outcome Odds ratio (95% CI)*
Non-survivors
(n=122)
Survivors
(n=1413)
Univariable analysis Multivariable analysis
Severe sepsis 110 (90%) 630 (45%) 5·1 (2·6–10·0) 5·3 (2·7–10·4)
Bacteria identiﬁ ed 45 (37%) 364 (26%) 1·1 (0·7–1·8) 1·0 (0·6–1·5)
Viruses identiﬁ ed 13 (11%) 434 (31%) 0·5 (0·3–1·0) 0·5 (0·3–0·9)
Data are n (%) unless otherwise stated. *Stratiﬁ ed by age groups and study sites. 
Table 3: Risk factors for 28-day mortality in patients with sepsis
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used for a single disease based on clinical suspicion; 
therefore, patients presenting with atypical symptoms 
are commonly misdiagnosed or undiagnosed. For 
example, rickettsioses, leptospirosis, and dengue are 
commonly found in patients presenting with acute 
CNS infections in southeast Asia,26,27 which is consistent 
with our results.
Our ﬁ ndings strongly support the recommendation of 
SSC to obtain blood cultures before administration of 
antibiotics within 3 h for patients presenting with sepsis.3 
Bacteraemia was commonly observed in both age groups 
in our study (12% in adult patients and 5% in paediatric 
patients). Susceptibility testing of the bacterial agents 
identiﬁ ed from blood could be used to adjust or 
de-escalate antimicrobial drugs.
Our ﬁ ndings indicate that severe sepsis is associated 
with increased mortality. This strongly suggests that 
patients suspected of infection should be routinely 
screened for signs of tissue hypoperfusion or organ 
dysfunction, and patients with severe sepsis should 
immediately receive intensive care and organ support.3 
We also show that adult patients with sepsis deﬁ ned by 
the 2014 task force (SOFA score ≥2) are also associated 
with higher mortality, which supports the use of the new 
sepsis deﬁ nition.14
In view of the mortality associated with severe sepsis, 
clinicians should provide the most eﬀ ective empirical 
management even before a microbiological diagnosis is 
conﬁ rmed. Our results highlight the diverse causes of 
sepsis that should be considered in a patient’s 
diﬀ erential. For example, the clinical presentations of 
dengue and leptospirosis overlap, and both were 
common in our patient population. If a patient is 
managed for presumed dengue with supportive care 
but actually has leptospirosis, an opportunity for 
eﬀ ective antimicrobial intervention will be missed. 
Awareness of the epidemiology of sepsis will help 
clinicians develop the most appropriate diﬀ erential to 
guide empirical treatment before a microbiological 
diagnosis is known.
On the basis of our ﬁ ndings, the ﬁ rst broad-spectrum 
antibiotics for patients with severe sepsis in southeast 
Asia should cover both Gram-negative and Gram-
positive bacteria, for example a combination of 
ceftriaxone plus doxycycline, or a combination of 
ceftazidime plus doxycycline. Doxycycline might need to 
be included as commonly used empirical antimicrobials 
such as beta-lactams and carbapenems are not eﬀ ective 
against O tsutsugamushi.28,29 Doxycycline can be used 
even in children younger than 8 years.30 In areas 
where melioidosis is endemic, the third-generation 
cephalosporin might need to be ceftazidime as other 
third-generation cephalosporins are ineﬀ ective against 
B pseudomallei.21
A pathogen was only identiﬁ ed in about half of sepsis 
patients. This ﬁ nding is comparable with other studies in 
the region.6–10 For example, a microbiological cause of 
fever was only identiﬁ ed in 41% of fever episodes in 
southern Laos,6 52% in two study sites in Laos,7 and 
47% in Cambodia.8 D’Acremont and colleagues4 reported 
that 88% of paediatric patients in Tanzania had 
microbiological evidence, and the high proportion of 
microbiological evidence found could be due to the 
diﬀ erent diagnostic tests used and the diﬀ erent setting. 
In our study, a proportion of patients without pathogen 
identiﬁ ed could have been infected by one of the agents 
we targeted because the sensitivity of collected specimens 
and reference diagnostic tests is not 100%.31 Also, many 
patients in our settings might have taken antibiotics 
before hospital admission. An alternative explanation is 
that patients were infected by pathogens that were not 
targeted by our diagnostic tests. Further studies in this 
group of patients are still required.
Our study has several potential limitations. First, the 
decision to perform some diagnostic tests in predeﬁ ned 
subsets of patients with relevant symptoms could lead 
to misdiagnosis of some infectious diseases. However, 
this represents the variable clinical presentations of 
tropical infectious diseases. Second, in some patients, 
the pathogens identiﬁ ed might not be the cause of 
sepsis. It is possible that some pathogenic viruses and 
bacteria could be found in the nasopharyngeal cavity of 
healthy patients, and background sero-positivity for 
rickettsiosis and leptospirosis is also a possibility in 
people living in endemic areas. The presence of viruses 
in the nasopharyngeal cavity of healthy people in a 
previous study32 conducted in China was not high. 
Furthermore, we used conservative criteria for 
microbiological evidence, such as high cutoﬀ s for 
serological tests for ricketsiosis and leptospirosis 
(appendix). Therefore, in most patients, the pathogens 
identiﬁ ed were likely to be the causes of sepsis. Further 
studies in healthy people in southeast Asia are also 
needed. Third, the study did not reach the target sample 
size in Indonesia. Nonetheless, we did not observe 
major diﬀ erences between the causes and outcomes of 
sepsis patients in Indonesia, Thailand, and Vietnam. 
Fourth, the study was conducted at tertiary-care 
hospitals in southeast Asia. Sepsis in other settings may 
be caused by diﬀ erent distribution of pathogens.
Our study highlights the diverse causes of sepsis 
and their variable clinical manifestations, the need 
for multiplex RDTs for tropical infectious diseases, 
the substantial mortality of sepsis, and the use of 
the sepsis diagnostic criteria and the SSC recom-
mendations in three middle-income countries in 
southeast Asia.
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